Read our latest reports on Latin America here, with analyses and ...
Read our latest reports on Latin America here, with analyses and market statistics that explore the evolving consumer preferences, market environment and inherent growth potential in individual countries, or briefings that assess key strategic themes...
Bolivia has managed to protect itself to a large extent from inflation by continuing to have a fixed exchange rate against the dollar. However, there has been challenges for the economy in 2023, with sharp falls in foreign currency reserves and this…
During 2023, Argentina was plunged into an economic crisis, with the rate of inflation soaring to more than 100%, one of the highest in the world. With the country already struggling to comply with the conditions of a loan package from the…
Pharmacies continue to have significant influence over the value sales of analgesics in Ecuador. For instance, in lower income neighbourhoods, pharmacies are generally stocked with generics, whereas in wealthier neighbourhoods, mainly branded…
Analgesics has not seen a positive performance in 2023 as the height of the pandemic has passed. During the pandemic’s peak, consumers were buying up analgesics at a rapid pace to treat fevers, aches and other symptoms associated with acute…
After the spike in demand for systemic analgesics in the period, 2020 to 2021, driven by COVID-19 and then by the need to relieve reactions to vaccination, in 2022 demand tended to stabilise. However, adult acetaminophen and combination analgesics…
In 2023, acetaminophen continues to lead sales of analgesics in Chile, whilst also experiencing the highest growth rate in the category. This growth has remained steady since the onset of the pandemic, where acetaminophen became the preferred choice…
While analgesics performed well during the pandemic, they has returned to more moderate growth now that the threat has subsided. In 2023, analgesics is expected to register moderate current value growth, though constant value sales are expected to…
Retail volume sales of analgesics rebounded in 2023, following a two-year period of decline. While the COVID-19 pandemic boosted demand for acetaminophen (paracetamol), which was the only analgesic recommended by the government to alleviate the…
The growth of sports and indoor and outdoor activities, as well as children returning to school, has led to increased injuries compared to the previous years of COVID-19 restrictions. This, in turn, has driven the demand for first aid products in…
During 2022 and 2023, Ozempic injections have started to be used by consumers who do not have type 2 diabetes to lose weight. Popularised by international media, higher-income consumers who can afford them have resorted to using these injections to…